Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 1.9T | 1.6T | 733.0B | 1.1T |
Cost of revenue | 1.5T | 1.4T | 593.0B | 907.4B |
Gross profit | 358.1B | 254.1B | 140.0B | 212.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 15.1B | 10.2B | 9.3B | 6.6B |
Other operating expenses | 4.3B | -2.5B | 4.3B | 1.2B |
Operating income | 277.1B | 176.4B | 66.6B | 125.5B |
Non operating interest income | ||||
Income | 5.5B | 2.8B | 6.5B | 4.8B |
Expense | 3.2B | 2.4B | 1.6B | 2.5B |
Other income expense | — | — | — | — |
Pretax income | 285.1B | 195.3B | 73.6B | 130.7B |
Tax provision | 66.8B | 46.7B | 15.4B | 25.5B |
Net income | 218.3B | 148.7B | 58.2B | 105.2B |
Basic EPS | — | — | — | 34 |
Diluted EPS | — | — | — | 34 |
Basic average shares | — | — | — | 3.1B |
Diluted average shares | — | — | — | 3.1B |
EBITDA | 291.0B | 200.3B | 77.6B | 135.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |